Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same author

Epigenetic Regulation of the NET Formation-Blood-Brain Barrier Axis in Ischemic Stroke: Mechanisms, Therapeutic Targets and Translational Perspectives.

Neurology international·2026
Same author

A Roadmap to Navigate the Future of Neural Engineering.

Journal of neural engineering·2026
Same author

Friend, Not Foe: Lowered Tissue Reactivity to Long-Term Polyimide Implants.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

How the visual brain can learn to parse images using a multiscale, incremental grouping process.

PLoS computational biology·2026
Same author

Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5.

Frontiers in immunology·2026

関連する実験動画

Updated: Jul 4, 2026

Multi-Scale Modification of Metallic Implants With Pore Gradients, Polyelectrolytes and Their Indirect Monitoring In vivo
12:19

Multi-Scale Modification of Metallic Implants With Pore Gradients, Polyelectrolytes and Their Indirect Monitoring In vivo

Published on: July 1, 2013

11.3K

フレンド、敵ではない：長期ポリイミドインプラントに対する組織反応性の低下

Corinne Orlemann, Laura M De Santis, Paul Neering

    bioRxiv : the preprint server for biology
    |February 23, 2026
    PubMed
    まとめ

    柔軟なポリイミドプローブは、硬いシリコンプローブと比較して、脳組織の損傷と炎症を大幅に軽減します。この発見は、脳組織との統合を改善するための、より優れた神経技術インプラントの設計に重要な洞察を提供します。

    キーワード:
    神経技術脳インプラントポリイミド組織反応神経科学生体材料

    さらに関連する動画

    Environmental Dynamic Mechanical Analysis to Predict the Softening Behavior of Neural Implants
    06:59

    Environmental Dynamic Mechanical Analysis to Predict the Softening Behavior of Neural Implants

    Published on: March 1, 2019

    8.4K
    Chronic Implantation of Multiple Flexible Polymer Electrode Arrays
    08:54

    Chronic Implantation of Multiple Flexible Polymer Electrode Arrays

    Published on: October 4, 2019

    11.4K

    関連する実験動画

    Last Updated: Jul 4, 2026

    Multi-Scale Modification of Metallic Implants With Pore Gradients, Polyelectrolytes and Their Indirect Monitoring In vivo
    12:19

    Multi-Scale Modification of Metallic Implants With Pore Gradients, Polyelectrolytes and Their Indirect Monitoring In vivo

    Published on: July 1, 2013

    11.3K
    Environmental Dynamic Mechanical Analysis to Predict the Softening Behavior of Neural Implants
    06:59

    Environmental Dynamic Mechanical Analysis to Predict the Softening Behavior of Neural Implants

    Published on: March 1, 2019

    8.4K
    Chronic Implantation of Multiple Flexible Polymer Electrode Arrays
    08:54

    Chronic Implantation of Multiple Flexible Polymer Electrode Arrays

    Published on: October 4, 2019

    11.4K

    科学分野:

    • 神経科学
    • 生体材料科学
    • 医療機器工学

    背景:

    • 脳組織によく耐容される神経技術インプラントの設計は、大きな課題です。
    • デバイスの設計の最適化は、機能性、移植性、および長期的な成功にとって重要です。

    研究 の 目的:

    • プローブの設計パラメータの変更が脳内の組織損傷と免疫応答にどのように影響するかを体系的に分析すること。
    • 組織損傷を軽減し、皮質内電極アレイの寿命を改善する設計上の特徴を特定すること。

    主な方法:

    • マウスの脳皮質に、厚さや幅が異なる硬いシリコンまたは柔軟なポリイミドプローブ103個を移植しました。
    • 組織の喪失、神経細胞密度、および星状細胞/ミクログリアの免疫応答を定量化するための自動ワークフローを開発しました。
    • 皮質深度全体にわたる組織マーカーを分析しました。

    主要な成果:

    • 柔軟なポリイミドプローブは、硬いシリコンプローブと比較して、病変が大幅に少なく、免疫応答も弱いことが示されました。
    • プローブシャンクの断面は、組織反応に対する影響がそれほど顕著ではありませんでした。
    • 免疫反応性は、デバイスの挿入部位と皮質-白質境界に集中していました。

    結論:

    • 柔軟なポリイミドプローブは、脳組織の損傷と炎症を最小限に抑える上で、硬いシリコンプローブよりも優れています。
    • デバイスの設計パラメータ、特に材料の柔軟性は、神経インプラントの統合を成功させるために重要です。
    • この調査結果は、神経技術の設計と外科的インプラント技術の最適化に貴重な洞察を提供します。